| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K58730230 |
| PharmacoGx | BRD-K58730230 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LINS1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.07 |
| mRNA | DDX39B | CTRPv2 | pan-cancer | AAC | -0.14 | 0.07 |
| mRNA | NKX2-4 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.07 |
| mRNA | RNF144A | CTRPv2 | pan-cancer | AAC | -0.15 | 0.07 |
| mRNA | GLRA1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | DHX8 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |
| mRNA | C18orf21 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | SPERT | CTRPv2 | pan-cancer | AAC | 0.14 | 0.07 |
| mRNA | SLC50A1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.07 |
| mRNA | PLEKHA5 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.07 |
